In the last trading session, 1.07 million shares of the Ideaya Biosciences Inc (NASDAQ:IDYA) were traded, and its beta was 0.27. Most recently the company’s share price was $16.98, and it changed around -$0.13 or -0.76% from the last close, which brings the market valuation of the company to $1.49B. IDYA currently trades at a discount to its 52-week high of $44.42, offering almost -161.6% off that amount. The share price’s 52-week low was $13.45, which indicates that the current value has risen by an impressive 20.79% since then. We note from Ideaya Biosciences Inc’s average daily trading volume that its 10-day average is 2.02 million shares, with the 3-month average coming to 1.12 million.
Ideaya Biosciences Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.15. If we narrow it down even further, the data shows that 0 out of 14 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 1 recommended IDYA as a Hold, whereas 11 deemed it a Buy, and 0 rated it as Underweight.
Ideaya Biosciences Inc (NASDAQ:IDYA) trade information
Instantly IDYA has showed a red trend with a performance of -0.76% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 17.30 on recent trading dayincreased the stock’s daily price by 1.85%. The company’s shares are currently down -33.93% year-to-date, but still up 17.10% over the last five days. On the other hand, Ideaya Biosciences Inc (NASDAQ:IDYA) is -11.24% down in the 30-day period. We can see from the shorts that 9.95 million shares have been sold at a short interest cover period of 10.41 day(s).
The consensus price target as assigned by Wall Street analysts is $38.5, which translates to bulls needing to increase their stock price by 55.9% from its current value. Analyst projections state that IDYA is forecast to be at a low of $27 and a high of $50.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -0.01%. Ideaya Biosciences Inc earnings are expected to increase by 16.94% in 2025, but the outlook is positive 15.86% per year for the next five years.
IDYA Dividends
Ideaya Biosciences Inc’s next quarterly earnings report is expected to be released on 2025-Feb-12.
Ideaya Biosciences Inc (NASDAQ:IDYA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.04% of Ideaya Biosciences Inc shares, and 109.58% of them are in the hands of institutional investors. The stock currently has a share float of 110.73%. Ideaya Biosciences Inc stock is held by 291.0 institutions, with FMR LLC being the largest institutional investor. By 2024-06-30, it held 14.4557% of the shares, which is about 11.27 million shares worth $395.69 million.
BLACKROCK INC., with 8.7321% or 6.81 million shares worth $239.02 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Feb 28, 2025 . The former held 4.1 shares worth $69.61 million, making up 4.68% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 2.71 shares worth around $45.94 million, which represents about 3.09% of the total shares outstanding.
